Rheumatoid Arthritis News

The FDA has issued a safety alert regarding a clinical study that has found a 10-mg, twice-daily dose of tofacitinib increased the risk for pulmonary embolism and mortality in patients with rheumatoid arthritis.

SCOTTSDALE, Ariz. — Rheumatologists are often less familiar with, and need to better manage, cardiovascular risk factors in patients with rheumatoid arthritis, according to an expert at the annual Basic and Clinical Immunology for the Busy Clinician symposium.

SCOTTSDALE, Ariz. — Growing evidence suggests that behavioral choices, including avoidance of excess alcohol, drugs and smoking, as well as engaging in exercise and healthy eating could have significant impact on the onset and course of immune-mediated inflammatory diseases, according to a presentation here.

SCOTTSDALE, Ariz. — Due to the diversity of its expression, psoriatic arthritis is not often able to take full advantage of treatments for similar inflammatory arthritides or psoriasis, according to a presentation here.

SCOTTSDALE, Ariz. — Despite various options, there is a similar safety profile across JAK inhibitors, according to an expert at the Annual Basic and Clinical Immunology for the Busy Clinician symposium.

Patients with rheumatoid arthritis who are at greatest risk for developing cardiovascular disease are largely unaware of the comorbidity, according to recent data in Arthritis Research & Therapy.

The specialty of rheumatology has become increasingly popular over the past several years for physicians who have completed their residencies, which has been attributed to a variety of factors, including lifestyle, job satisfaction, job availability, mentorship opportunities, and intellectual interest.

In recognition of Rheumatoid Awareness Day on Feb. 2, at-home health testing platform Imaware has announced it will match all donations to the Rheumatoid Patient Foundation up to $10,000 through Feb. 12, according to a press release.

Initiating treatment with intensive combinations of conventional disease modifying antirheumatic drugs achieves comparable outcomes as treatment with TNF inhibitors, but at a significantly lower cost, among patients with rheumatoid arthritis, according to data published in Arthritis Care & Research.

Women with rheumatoid arthritis who are treated with assisted reproductive technology, or ART, have a significantly reduced chance of live birth compared to those without rheumatoid arthritis, according to data published in the Annals of the Rheumatic Diseases.